Research Library
Endocrine Research

PT-141: Reported Benefits, Side Effects and the State of the Evidence

Also referenced as: Endocrine Research

Preclinical data 99% purity COA verifiedResearch use only

A literature-led overview of PT-141 — what has actually been measured in the published record, what remains unknown, and how research-grade material is characterised.

5 min read · Literature review · Updated 2026

Research-grade PT-141 vials — ≥99% HPLC purity, lot-matched COA on request, from $23.99.

Shop PT-141

What PT-141 is

Melanocortin receptor agonist used in MC3R/MC4R receptor research.

Research material is supplied as a lyophilised powder in a sealed vial, reconstituted with bacteriostatic water immediately before use and characterised by reverse-phase HPLC with identity confirmed by mass spectrometry. The published record for PT-141 is dominated by preclinical sources, which is the most important caveat when reading any summary of its reported effects.

Reported benefits of PT-141 in the literature

The areas below summarise what published work has actually measured. Each is an observation reported in the cited literature — not a claimed outcome, and not a statement of efficacy in humans.

  • Melanocortin receptor assays

    In published literature, researchers have investigated investigated in published literature and laboratory work covering melanocortin receptor assays. Findings are research observations only and make no claim about human use.

  • Neuroendocrine signalling

    In published literature, researchers have investigated investigated in published literature and laboratory work covering neuroendocrine signalling. Findings are research observations only and make no claim about human use.

How it is described mechanistically

Mechanistic descriptions of PT-141 in the literature centre on the pathways below. Pathway attributions should be read as proposed rather than settled.

  • Proposed pathways

    Mechanistic detail for this compound is documented mainly in analytical and preclinical sources. Pathway data should be treated as proposed rather than established.

PT-141 side effects and safety data gaps

Because many research peptides have limited controlled human data, safety profiles may be incomplete. This section summarizes reported safety signals from published literature and does not establish safety for human use.

No consistent adverse-event profile has been established for PT-141. The meaningful limitation is absence of data rather than a documented list of effects.

Open data gaps: controlled human trials, chronic exposure data, regulatory review status. Peptide Lounge does not publish dosing or administration guidance for any compound, and this material is not for human or veterinary use.

Purity, testing and handling for research use

Every PT-141 lot is released at ≥99% purity by RP-HPLC with identity confirmed by ESI-MS, and a lot-matched certificate of analysis is available on request rather than a generic sample document.

Vials ship lyophilised and sealed, and are stable at ambient temperature during transit. Store unreconstituted vials refrigerated and protected from light; once reconstituted, keep refrigerated and treat the solution as short-dated. Experimental concentrations must be determined by the researcher from the peer-reviewed literature under their own institutional protocol.

How researchers source PT-141

PT-141 is stocked as a 10mg single-compound vial, with volume pricing applied automatically to multi-vial orders. Free bacteriostatic water and research supplies are included on qualifying orders.

Related research vials

PT-141 — frequently asked questions

What are the reported benefits of PT-141?

Published work describes melanocortin receptor assays, neuroendocrine signalling. These findings come from preclinical or in-vitro studies rather than controlled human trials.

What side effects have been reported for PT-141?

No established adverse-event profile exists. The substantive limitation is missing data: controlled human trials, chronic exposure data, regulatory review status.

Is PT-141 approved for human use?

No. PT-141 supplied by Peptide Lounge is a laboratory reagent for in-vitro and laboratory research only. It is not an approved drug and is not for human or veterinary use.

How is PT-141 stored and reconstituted?

Store lyophilised vials refrigerated and protected from light. Reconstitute with bacteriostatic water immediately before use and keep the resulting solution refrigerated. Vials remain stable at ambient temperature during shipping.

How do I verify the purity of a PT-141 vial?

Request the lot-matched certificate of analysis for the batch you received. It reports RP-HPLC purity (≥99%) and ESI-MS identity confirmation for that specific lot.

Research areas

Melanocortin receptor assays

Preclinical data

In published literature, researchers have investigated investigated in published literature and laboratory work covering melanocortin receptor assays. Findings are research observations only and make no claim about human use.

  • • Limitation: Evidence for this area is drawn from preclinical or analytical work.

Neuroendocrine signalling

Preclinical data

In published literature, researchers have investigated investigated in published literature and laboratory work covering neuroendocrine signalling. Findings are research observations only and make no claim about human use.

  • • Limitation: Evidence for this area is drawn from preclinical or analytical work.

Mechanisms of action (as described in literature)

Proposed pathways

Mechanistic data

Mechanistic detail for this compound is documented mainly in analytical and preclinical sources. Pathway data should be treated as proposed rather than established.

Published studies

No peer-reviewed study links are curated for this compound yet. Available information is limited to analytical and preclinical sources. Absence of linked studies should be read as an evidence gap.

Safety signals & data gaps

Reported signals only — safety is not established

Because many research peptides have limited controlled human data, safety profiles may be incomplete. This section summarizes reported safety signals from published literature and does not establish safety for human use.

Known data gaps: Controlled human trials, Chronic exposure data, Regulatory review status.

For Research Use Only

All products listed are supplied strictly as laboratory reagents for in-vitro research and analytical work conducted by qualified professionals. They are not drugs, foods, cosmetics or medical devices, and must not be administered to humans or animals. No product on this site is approved by the FDA for human use.

Research Use Only: Products are sold strictly for laboratory research and educational purposes only. Not for human consumption, veterinary use, food use, cosmetic use, or therapeutic application. Products are not intended to diagnose, treat, cure, or prevent any disease.